vs

Side-by-side financial comparison of Arcosa, Inc. (ACA) and Dolby Laboratories, Inc. (DLB). Click either name above to swap in a different company.

Arcosa, Inc. is the larger business by last-quarter revenue ($716.7M vs $395.6M, roughly 1.8× Dolby Laboratories, Inc.). Dolby Laboratories, Inc. runs the higher net margin — 24.0% vs 7.3%, a 16.7% gap on every dollar of revenue. On growth, Arcosa, Inc. posted the faster year-over-year revenue change (7.6% vs 7.1%). Over the past eight quarters, Dolby Laboratories, Inc.'s revenue compounded faster (13.9% CAGR vs 9.4%).

Arcosa, Inc. is a provider of infrastructure-related products and solutions operating across three core segments: construction, energy, and transportation. It offers products including utility structures, construction aggregates, and transportation components, primarily serving customers across the North American market to support critical infrastructure development projects.

Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.

ACA vs DLB — Head-to-Head

Bigger by revenue
ACA
ACA
1.8× larger
ACA
$716.7M
$395.6M
DLB
Growing faster (revenue YoY)
ACA
ACA
+0.5% gap
ACA
7.6%
7.1%
DLB
Higher net margin
DLB
DLB
16.7% more per $
DLB
24.0%
7.3%
ACA
Faster 2-yr revenue CAGR
DLB
DLB
Annualised
DLB
13.9%
9.4%
ACA

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ACA
ACA
DLB
DLB
Revenue
$716.7M
$395.6M
Net Profit
$52.1M
$94.9M
Gross Margin
22.9%
88.7%
Operating Margin
11.0%
28.5%
Net Margin
7.3%
24.0%
Revenue YoY
7.6%
7.1%
Net Profit YoY
776.6%
3.4%
EPS (diluted)
$1.06
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACA
ACA
DLB
DLB
Q2 26
$395.6M
Q1 26
$346.7M
Q4 25
$716.7M
$346.7M
Q3 25
$797.8M
$307.0M
Q2 25
$736.9M
$315.5M
Q1 25
$632.0M
$369.6M
Q4 24
$666.2M
$357.0M
Q3 24
$640.4M
$304.8M
Net Profit
ACA
ACA
DLB
DLB
Q2 26
$94.9M
Q1 26
$53.3M
Q4 25
$52.1M
$53.3M
Q3 25
$73.0M
$49.3M
Q2 25
$59.7M
$46.1M
Q1 25
$23.6M
$91.8M
Q4 24
$-7.7M
$67.8M
Q3 24
$16.6M
$58.6M
Gross Margin
ACA
ACA
DLB
DLB
Q2 26
88.7%
Q1 26
87.5%
Q4 25
22.9%
87.5%
Q3 25
24.1%
87.1%
Q2 25
22.5%
86.1%
Q1 25
19.8%
90.3%
Q4 24
19.3%
88.6%
Q3 24
21.3%
88.8%
Operating Margin
ACA
ACA
DLB
DLB
Q2 26
28.5%
Q1 26
17.9%
Q4 25
11.0%
17.9%
Q3 25
14.1%
9.7%
Q2 25
12.9%
15.1%
Q1 25
8.8%
29.2%
Q4 24
6.5%
22.4%
Q3 24
5.3%
15.2%
Net Margin
ACA
ACA
DLB
DLB
Q2 26
24.0%
Q1 26
15.4%
Q4 25
7.3%
15.4%
Q3 25
9.2%
16.1%
Q2 25
8.1%
14.6%
Q1 25
3.7%
24.8%
Q4 24
-1.2%
19.0%
Q3 24
2.6%
19.2%
EPS (diluted)
ACA
ACA
DLB
DLB
Q2 26
$0.99
Q1 26
$0.55
Q4 25
$1.06
$0.55
Q3 25
$1.48
$0.50
Q2 25
$1.22
$0.48
Q1 25
$0.48
$0.94
Q4 24
$-0.16
$0.70
Q3 24
$0.34
$0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACA
ACA
DLB
DLB
Cash + ST InvestmentsLiquidity on hand
$214.6M
$594.7M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$2.6B
$2.6B
Total Assets
$5.0B
$3.2B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACA
ACA
DLB
DLB
Q2 26
$594.7M
Q1 26
$644.6M
Q4 25
$214.6M
$644.6M
Q3 25
$220.0M
$702.6M
Q2 25
$189.7M
$699.3M
Q1 25
$167.9M
$626.6M
Q4 24
$187.3M
$520.8M
Q3 24
$756.8M
$482.0M
Total Debt
ACA
ACA
DLB
DLB
Q2 26
Q1 26
Q4 25
$1.5B
Q3 25
$1.6B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.2B
Stockholders' Equity
ACA
ACA
DLB
DLB
Q2 26
$2.6B
Q1 26
$2.6B
Q4 25
$2.6B
$2.6B
Q3 25
$2.6B
$2.6B
Q2 25
$2.5B
$2.6B
Q1 25
$2.5B
$2.6B
Q4 24
$2.4B
$2.5B
Q3 24
$2.4B
$2.5B
Total Assets
ACA
ACA
DLB
DLB
Q2 26
$3.2B
Q1 26
$3.2B
Q4 25
$5.0B
$3.2B
Q3 25
$5.1B
$3.2B
Q2 25
$5.0B
$3.2B
Q1 25
$4.9B
$3.2B
Q4 24
$4.9B
$3.2B
Q3 24
$4.4B
$3.1B
Debt / Equity
ACA
ACA
DLB
DLB
Q2 26
Q1 26
Q4 25
0.57×
Q3 25
0.61×
Q2 25
0.67×
Q1 25
0.68×
Q4 24
0.69×
Q3 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACA
ACA
DLB
DLB
Operating Cash FlowLast quarter
$120.0M
$147.3M
Free Cash FlowOCF − Capex
$55.8M
FCF MarginFCF / Revenue
7.8%
Capex IntensityCapex / Revenue
9.0%
Cash ConversionOCF / Net Profit
2.30×
1.55×
TTM Free Cash FlowTrailing 4 quarters
$175.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACA
ACA
DLB
DLB
Q2 26
$147.3M
Q1 26
$54.8M
Q4 25
$120.0M
$54.8M
Q3 25
$160.6M
$472.2M
Q2 25
$61.2M
$67.7M
Q1 25
$-700.0K
$174.9M
Q4 24
$248.2M
$106.8M
Q3 24
$135.0M
$327.3M
Free Cash Flow
ACA
ACA
DLB
DLB
Q2 26
Q1 26
Q4 25
$55.8M
$50.2M
Q3 25
$121.0M
$435.9M
Q2 25
$33.4M
$61.3M
Q1 25
$-34.7M
$168.0M
Q4 24
$194.9M
$100.0M
Q3 24
$100.6M
$297.2M
FCF Margin
ACA
ACA
DLB
DLB
Q2 26
Q1 26
Q4 25
7.8%
14.5%
Q3 25
15.2%
142.0%
Q2 25
4.5%
19.4%
Q1 25
-5.5%
45.5%
Q4 24
29.3%
28.0%
Q3 24
15.7%
97.5%
Capex Intensity
ACA
ACA
DLB
DLB
Q2 26
Q1 26
Q4 25
9.0%
1.3%
Q3 25
5.0%
11.8%
Q2 25
3.8%
2.0%
Q1 25
5.4%
1.9%
Q4 24
8.0%
1.9%
Q3 24
5.4%
9.8%
Cash Conversion
ACA
ACA
DLB
DLB
Q2 26
1.55×
Q1 26
1.03×
Q4 25
2.30×
1.03×
Q3 25
2.20×
9.57×
Q2 25
1.03×
1.47×
Q1 25
-0.03×
1.91×
Q4 24
1.57×
Q3 24
8.13×
5.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACA
ACA

Engineered Structures$301.1M42%
Total Construction Materials$276.8M39%
Specialty Materials And Asphalt$110.2M15%
Construction Site Support$28.6M4%

DLB
DLB

Licensing$372.2M94%
Products and services$23.4M6%

Related Comparisons